0001171843-15-000598.txt : 20150204
0001171843-15-000598.hdr.sgml : 20150204
20150204160612
ACCESSION NUMBER: 0001171843-15-000598
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150201
FILED AS OF DATE: 20150204
DATE AS OF CHANGE: 20150204
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AKORN INC
CENTRAL INDEX KEY: 0000003116
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 720717400
STATE OF INCORPORATION: LA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1925 W. FIELD COURT, SUITE 300
CITY: LAKE FOREST
STATE: IL
ZIP: 60045
BUSINESS PHONE: 847-279-6100
MAIL ADDRESS:
STREET 1: 1925 W. FIELD COURT, SUITE 300
CITY: LAKE FOREST
STATE: IL
ZIP: 60045
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Dick Timothy A
CENTRAL INDEX KEY: 0001466630
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32360
FILM NUMBER: 15575469
MAIL ADDRESS:
STREET 1: 1925 WEST FIELD COURT SUITE 300
CITY: LAKE FOREST
STATE: IL
ZIP: 60045
4
1
formfour.xml
X0306
4
2015-02-01
0
0000003116
AKORN INC
AKRX
0001466630
Dick Timothy A
1925 WEST FIELD COURT SUITE 300
LAKE FOREST
IL
60045
0
1
0
0
Chief Financial Officer
Common Stock
2015-02-01
4
M
0
61111
2.61
A
246311
D
Common Stock
2015-02-01
4
S
0
30750
42.19
D
215561
D
Stock Option (right to buy)
2.61
2015-02-01
4
M
0
61111
0
D
2015-05-21
Common Stock
61111
0
D
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 15, 2014.
Upon execution of transactions disclosed on this Form 4, all securities subject to the 10b5-1 trading plan have been transacted and the plan has expired pursuant to its terms.
All proceeds from the sale were used to cover exercise price and taxes due upon exercise of options.
Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $41.81 to $42.93 per share. The reporting person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at separate prices within the foregoing range.
Amount of Shares Beneficially Owned Following Reported Transaction includes 45,789 unvested shares subject to a restricted stock awards and 169,772 shares owned outright.
The option vested in three annual installments with 122,222 options vesting on each of May 21, 2011 and May 21, 2012, and 122,223 options vesting on May 21, 2013.
Exercise of stock options that were approaching their 5-year expiration date.
There was no consideration given in exchange for the security.
/s/ Timothy A. Dick
2015-02-04